Clinical Trial Update: EBV-AST Cell Therapy for EBV-Related Diseases After Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating EBV-AST cell therapy for Epstein-Barr virus-related diseases after stem cell transplantation, currently recruiting. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus Infection
• Post-transplant Lymphoproliferative Disorder

Drugs mentioned

• EBV-AST Cell Therapy

Snippet

Sponsor: Daihong Liu | Conditions: EBV-DNA Viremia, Post-Transplant Lymphoproliferative Disorder | Phase 1, Phase 2 | Status: RECRUITING